Tivic Health Systems, Inc. (TIVC) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Tivic Health Systems, Inc.

TIVC

NASDAQ

Unprofitable

Medical - Devices

Next Earning date - 21 May 2025

Medical - Devices

Next Earning date - 21 May 2025

7.12USD

0.08 ( 1.14%)

Market Closed (as of Apr 25, 20:00 EDT)

Relative Strenght

100

Volume Buzz

-85%

Earning Acce

Yes

Dist 52w H.

77%

Overview Chart

Quote Panel

Updated April 27, 2025

1W 103.43 % 1M 153.38 % 3M 68.32 % 1Y -60.11 %

Key Metrics

Market Cap
4.42M
Shares Outstanding
620137
Share in Float
619265
Dividende
0

Earning Date
21 May 2025
Price Target
7.12
Average Volume
1.84M
Beta
2.158

Range
2.43-31.45
Industry
Medical - Devices
Website
https://www.tivichealth.com
Sector
Healthcare

Quote Panel

Updated April 27, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

5.66x

P/S Ratio

0.27x

P/B Ratio

0.0

Debt/Equity

-725.0%

Net Margin

$-19.7

EPS

How TIVC compares to sector?

P/E Ratio

Fundamentals

Relative Strength

TIVC

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

TIVC

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$8M

4363%

2025-Revenue

$8M

-395%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

-459.18
vs -89.99

Q4.22

N/A

-23.30
vs -55.72

Q1.23

N/A

-391.16
vs -391.16

Q2.23

N/A

-119.05
vs -544.22

Q3.23

N/A

-25.17
vs -459.18

Q4.23

N/A

-25.88
vs -23.30

Q1.24

N/A

-17.18
vs -391.16

Q2.24

N/A

-5.44
vs -119.05

Q3.24

N/A

-3.91
vs -25.17

Q4.24

N/A

-15.42
vs -25.88

Sales Growth

YoY

Current

Estimates

Q3.22

+72%

477K vs 277K

Q4.22

+11%

408K vs 366K

Q1.23

-12%

376K vs 428K

Q2.23

-70%

161K vs 528K

Q3.23

-41%

282K vs 477K

Q4.23

-12%

357K vs 408K

Q1.24

-11%

334K vs 376K

Q2.24

-13%

140K vs 161K

Q3.24

-55%

126K vs 282K

Q4.24

-50%

180K vs 357K

Return on Equity

QoQ

Q1.23

-41%

-0.41
vs -0.62

Q2.23

-67%

-0.67
vs -0.41

Q3.23

-31%

-0.31
vs -0.67

Q4.23

-63%

-0.63
vs -0.31

Q1.24

-69%

-0.69
vs -0.63

Q2.24

-30%

-0.30
vs -0.69

Q3.24

-50%

-0.50
vs -0.30

Q4.24

-58%

-0.58
vs -0.50

Institutionnal Ownership

QoQ

Q4.21

8
vs NA

Q1.22

6
vs 8

-25%

Q2.22

4
vs 6

-33%

Q3.22

3
vs 4

-25%

Q4.22

7
vs 3

133%

Q1.23

12
vs 7

71%

Q2.23

12
vs 12

Earnings Growth

Latest News

businesswire.com

8 hours ago

Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates

businesswire.com

8 hours ago

Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia

businesswire.com

8 hours ago

Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

businesswire.com

16 hours ago

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

businesswire.com

16 hours ago

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

seekingalpha.com

18 hours ago

Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript

Company Description

7.12USD

N/A

5.66x

0.27x

0.0

-725.0%

$-19.7

$8M

$8M

Earnings Growth

Latest News

Latest News

Latest News

$8M

$8M

Company Description

7.12USD

N/A

5.66x

0.27x

0.0

-725.0%

$-19.7